Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05966454 · ClinicalTrials.gov registry record · Phase 4

Complex And Simple Appendicitis: REstrictive or Liberal Post-operative Antibiotic eXposure - UCSF

A Phase 4 study of Appendicitis, sponsored by University of California, San Francisco.

Recruiting
Registry status
Phase 4
Development phase
145
Enrollment target
1
Study location

NCT05966454 is a Phase 4 study of Appendicitis that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 145 participants, below the 2,932-participant average among 8 other Appendicitis trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05966454, a Phase 4 study of Appendicitis, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
Phase 4
Development phase
145 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to demonstrate the safety, efficacy, and feasibility of short-course post-operative antibiotic treatment for simple and complicated appendicitis

Conditions Studied

Interventions

  • DRUG Multiple standard of care antibiotics for appendicitis, at physicians' discretion

Study Locations (1)

California

  • Zuckerberg San Francisco General Hospital - San Francisco

Trial Details

FieldValue
Enrollment Target 145 participants
Start Date 2023-06-06
Est. Completion 2026-06-30
Phase Phase 4

What the Registry Record Tells You About NCT05966454

The ClinicalTrials.gov registry entry for NCT05966454 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 145 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,932-participant average among 8 other Appendicitis trials with a reported enrollment target (95% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Appendicitis appearing as the primary indexed condition, and to 1 intervention - of which Multiple standard of care antibiotics for appendicitis, at physicians' discretion is the first listed.

NCT05966454 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05966454 about?

NCT05966454 is a clinical study titled "Complex And Simple Appendicitis: REstrictive or Liberal Post-operative Antibiotic eXposure - UCSF". The purpose of this study is to demonstrate the safety, efficacy, and feasibility of short-course post-operative antibiotic treatment for simple and complicated appendicitis

What is the current status of trial NCT05966454?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 145 participants. The study started on 2023-06-06. Estimated completion is 2026-06-30.

What conditions does trial NCT05966454 study?

This clinical trial studies the following conditions: Appendicitis.

What interventions are being tested in trial NCT05966454?

The interventions under investigation include: Multiple standard of care antibiotics for appendicitis, at physicians' discretion (DRUG).

Who is sponsoring clinical trial NCT05966454?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05966454 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Appendicitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.